Browsed by
Category: Energy and Commerce Committee

Senate appropriations bills provide a boost to DOE’s office of Science and a cut to NSF in 2018 ?>

Senate appropriations bills provide a boost to DOE’s office of Science and a cut to NSF in 2018

  The Senate Appropriations Committee has approved two draft funding bills for fiscal 2018 that conflict with appropriation bills proposed by the House earlier this month.  The House Appropriations Committee proposed flat funding for the National Science Foundation research programs and Department of Energy’s Office of Science. The Senate, however, is seeking to provide a slight cut and increase, respectively. Under the budgets put forth by the Senate Appropriations Committee, the NSF would receive $7.3 billion and the Department of…

Read More Read More

Floor debate begins on HR 6 – 21st Century Cures ?>

Floor debate begins on HR 6 – 21st Century Cures

With debate starting – here’s a summary of where the legislation stands as it heads to the House floor. If you’ve been following the progress of H.R. 6, the 21st Century Cures Act, you’ve seen momentum for the bill grow, and may have felt (like we did) that its passage is a foregone conclusion. It was only a few weeks ago that we reported on the House Energy and Commerce Committee’s bipartisan and unanimous passage of the bill out of…

Read More Read More

21st Century Cures Act passes committee ?>

21st Century Cures Act passes committee

Today, the U.S. House Energy and Commerce committee voted unanimously in favor of the 21st Century Cures Act, formally known as H.R. 6. Work on this legislation began over a year ago with the goal of speeding discovery, development and delivery of therapies and cures to patients. Should H.R. 6 become law, it would make important changes to the National Institutes of Health, the Food and Drug Administration and other federal agencies working on healthcare issues. The 21st Century Cures…

Read More Read More

Progress on the 21st Century Cures Act ?>

Progress on the 21st Century Cures Act

On Thursday, the U.S. House Energy and Commerce committee held a legislative hearing on the draft 21st Century Cures Act. This hearing was a forum for legislators to ask questions of Dr. Kathy Hudson, of the National Institutes of Health, and two Food and Drug Administration officials about provisions in the draft bill.

Another try for 21st Century Cures ?>

Another try for 21st Century Cures

Today, the U.S. House Energy and Commerce committee released a second draft of the 21st Century Cures Act. The original draft was released in January and contained several questionable provisions regarding the National Institutes of Health.

21st Century Cures Act introduced ?>

21st Century Cures Act introduced

Throughout most of 2014, the U.S. House Energy and Commerce committee was engaged in the 21st Century Cures initiative. The goal of this initiative was to speed the discovery, development and delivery of therapies for the myriad illnesses that affect Americans today.

What we’re watching in 2015: 21st Century Cures ?>

What we’re watching in 2015: 21st Century Cures

In this four-part series, we will take a look at important issues for the research community in 2015. Today’s topic is the 21st Century Cures initiative. In the spring of 2014, Reps. Diana DeGette, D-Colorado, and Fred Upton, R-Michigan, made an important announcement concerning scientists.

Support from the House for a “Path to 21st Century Cures” ?>

Support from the House for a “Path to 21st Century Cures”

Last week the U.S. Senate Appropriations committee highlighted the need to drive innovation through federal investments. This week, the U.S. House Energy and Commerce committee led by Rep. Fred Upton, R-Michigan, and Rep. Diana DeGette, D-Colorado, launched a new initiative called “A Path to 21st Century Cures.” This new initiative brought together leaders from the government, non-profit sector and private industry, including Francis Collins, director of the National Institutes of Health, Janet Woodcock, director of the Food and Drug Administration’s…

Read More Read More

Scrutiny on spending at the National Institutes of Health increasing ?>

Scrutiny on spending at the National Institutes of Health increasing

Science advocacy groups, such as the ASBMB, urge Congress to increase the budgets of the National Institutes of Health and other research-funding agencies to continue our national investment in groundbreaking research that will improve the public health and energize our economy. However, some members of Congress have begun to turn the tables suggesting that research funding agencies could fund more research if they were smarter with how they invested their money. The debate, though, is what qualifies as a smart…

Read More Read More